Comparison of features of human lung cancer cell lines and their corresponding tumors

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 991-1000

  Wistuba, Ignacio I ^a,c   Bryant, David ^a   Behrens, Carmen ^a   Milchgrub, Sara ^b   Virmani, Arvind K ^a,b   Ashfaq, Raheela ^b   Minna, John D ^a,b   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELISM; ANEUPLOIDY; ARTICLE; CANCER CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LUNG CANCER; LUNG NON SMALL CELL CANCER; ONCOGENE K RAS; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; ANEUPLOIDY; CARCINOMA, NON-SMALL-CELL LUNG; CELL CULTURE TECHNIQUES; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, P53; GENES, RAS; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTOR, ERBB-2; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032900869     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1998. CA Cancer J. Clin., 48: 6-29, 1998.
2. Parkin, D. M., Pisani, P., Lopez, A. D., and Masuyer, E. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int. J. Cancer, 5904: 494-504, 1994.
3. Colby, T. V., Koss, M. N., and Travis, W. D. Tumors of the lower respiratory tract, 3rd series, fascicle 13, pp. 1-554. Washington, DC: Armed Forces Institute of Pathology, 1995.
4. Sekido, Y., Fong, K. M., and Minna, J. D. Progress in understanding the molecular pathogenesis of human lung cancer. Biochim. Biophys. Acta. 1378: F21-F59, 1998.
5. Gazdar, A. F., and Minna, J. D. NCI series of cell lines: an historical perspective. J. Cell. Biochem. Suppl., 24: 1-11, 1996.
6. Minna, J. D., Sekido, Y., Fong, K., and Gazdar, A. F. Molecular biology of lung cancer. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, Ed. 5, pp. 849-857. Philadelphia: Lippincott, 1997.
7. Gazdar, A. F., Kurvari, V., Virmani, A., Gollahon, L., Sakaguchi, M., Westerfield, M., Kodagoda, D., Stasny, V., Cunningham, T., Wistuba, I. I., Tomlinson, G., Tonk, V., Ashfaq, R., Leitch, M., Minna, J. D., and Shay, J. W. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer, 78: 766-774, 1998.
8. Wistuba, I. I., Behrens, C., Milchgrub, S., Syed, S., Ahmadian, M., Virmani, A. K., Cunningham, T. H., Ashfaq, R., Minna, J. D., and Gazdar, A. F. Comparison of features of human breast cancer cell lines and their corresponding tumors. Clin. Cancer Res., 4: 2931-2938, 1998.
9. Johnson, B. E., Makuch, R. W., Simmons, A. D., Gazdar, A. F., Burch, D., and Cashell, A. W. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Cancer Res., 48: 5163-5166, 1988.
10. Oie, H. K., Russell, E. K., Carney, D. N., and Gazdar, A. F. Cell culture methods for the establishment of the NCI series of lung cancer cell lines. J. Cell. Biochem. Suppl., 24: 24-31, 1996.
11. Wistuba, I. I., Montellano, F. D., Milchgrub, S., Virmani, A. K., Behrens, C., Chen, H., Ahmadian, M., Nowak, J. A., Muller, C., Minna, J. D., and Gazdar, A. F. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res., 57: 3154-3158, 1997.
12. Sugio, K., Molberg, K., Albores-Saavedra, J., Virmani, A. K., Kishimoto, Y., and Gazdar, A. F. K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers. Int. J. Pancreatol., 21: 205-217, 1997.
13. Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhuang, Z., Goldstein, S. R., Weiss, R. A., and Liotta, L. A. Laser capture microdissection. Science (Washington DC), 274: 998-1001, 1996.
14. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D. D., Minna, J. D., and Gazdar, A. F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc., 273: 558-563, 1995.
15. Fondon, J. W., III, Mele, G. M., Brezinschek, R. I., Cummings, D., Pande, A., Wren, J., O'Brien, K. M., Kupfer, K. C., Wei, M. H., Lerman, M., Minna, J. D., and Garner, H. R. Computerized polymorphic marker identification: experimental validation and a predicted human polymorphism catalog. Proc. Natl. Acad. Sci. USA, 95: 7514-7519, 1998.
16. Wistuba, I. I., Behrens, C., Milchgrub, S., Virmani, A. K., Jagirdar, J., Thomas, B., Ioachim, H. L., Litzky, L. A., Brambilla, E. M., Minna, J. D., and Gazdar, A. F. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. J. Am. Med. Assoc., 279: 1554-1559, 1998.
17. Loeb, L. A. Cancer cells exhibit a mutator phenotype. Adv. Cancer Res., 72: 25-56, 1998.
18. Schneider, P. M., Hung, M. C., Chiocca, S. M., Manning, J., Zhao, X. Y., Fang, K., and Roth, J. A. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res., 49: 4968-4971, 1989.
19. Shi, D., He, G., Cao, S., Pan, W., Zhang, H. Z., Yu, D., and Hung, M. C. Overexpression of the c-erbB-2/neu-encoded p 185 protein in primary lung cancer. Mol. Carcinog., 5: 213-218, 1992.
20. Weiner, D. B., Nordberg, J., Robinson, R., Nowell, P. C., Gazdar, A., Greene, M. I., Williams, W. V., Cohen, J. A., and Kern, J. A. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res., 50: 421-425, 1990.
21. Kern, J. A., Robinson, R. A., Gazdar, A., Torney, L., and Weiner, D. B. Mechanisms of p185HER2 expression in human non-small cell lung cancer cell lines. Am. J. Respir. Cell Mol. Biol., 6: 359-363, 1992.
22. Tateishi, M., Ishida, T., Mitsudomi, T., Kaneko, S., and Sugimachi, K. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur. J. Cancer. 27: 1372-1375, 1991.
23. Kern, J. A., Slebos, R. J., Top, B., Rodenhuis, S., Lager, D., Robinson, R. A., Weiner, D., and Schwartz, D. A. c-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J. Clin. Invest., 93: 516-520, 1994.
24. Pfeiffer, P., Clausen, P. P., Andersen, K., and Rose, C. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small cell lung cancer: an immunohistochemical study on cryosections. Br. J. Cancer, 74: 86-91, 1996.
25. Baas, I. O., Mulder, J. W., Offerhaus, G. J., Vogelstein, B., and Hamilton, S. R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172: 5-12, 1994.
26. Greenblatt, M. S., Bennett, W. P., Hollatein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clue to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
27. Mitsudomi, T., Viallet, J., Mulshine, J. L., Linnoila, R. I., Minna, J. D., and Gazdar, A. F. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene, 6: 1353-1362, 1991.
28. Fishel, R. Genomic instability, mutators, and the development of cancer: is there a role for p53? J. Natl. Cancer Inst., 88: 1608-1609, 1996.
29. Fong, K. M., Zimmerman, P. V., and Smith, P. J. Microsatellite instability and other molecular abnormalities in non-small cell lung cancer. Cancer Res., 55: 28-30, 1995.
30. Adachi, J. I., Shiseki, M., Okazaki, T., Ishimuru, G., Noguchi, M., Hirohashi, S., and Yokota, Y. Microsatellite instability in primary and metastatic lung carcinomas. Genes Chromosomes Cancer, 14: 301-306, 1995.
31. Nowell, P. C. The clonal evolution of tumor cell populations. Science (Washington DC), 194: 23-28, 1976.
32. Stevenson, H., Gazdar, A. F., Phelps, R., Linnoila, R. I., Ihde, D. C., Ghosh, B., Walsh, T., Woods, E. L., Oie, H., O'Connor, T., and Mulshine, J. L. Tumor cell lines established in vitro: an independent prognostic factor for survival in non-small-cell lung cancer. Ann. Intern. Med., 113: 764-770, 1990.